Investor Relations 02.29.2024 Pfizer Oncology Innovation Day Presentation Infographic Transcript Webcast Overview Investor Relations Overview Why Invest Our Story Prospective Investors Sustainability Bond ESG Report Fact Sheet Investor Email Alerts Events & Presentations Financials Quarterly Results Annual Reports...
Watson Health and Pfizer announce a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer's research in immuno-oncology, an approach to cancer treatment that uses the body's immune system to help fight cancer. ...
Oncology Conquering Cancer Inflammation & Immunology Innovation, Research & Development Vaccines Driven to Discover the Cure Rare Disease Our Approach to Gene Therapy and More Internal Medicine Advancing the Fight Anti Infectives New Drugs, Medicines & Therapies ...
Oncology Conquering Cancer Inflammation & Immunology Innovation, Research & Development Vaccines Driven to Discover the Cure Rare Disease Our Approach to Gene Therapy and More Internal Medicine Advancing the Fight Anti Infectives New Drugs, Medicines & Therapies ...
Oncology Conquering Cancer Inflammation & Immunology Innovation, Research & Development Vaccines Driven to Discover the Cure Rare Disease Our Approach to Gene Therapy and More Internal Medicine Advancing the Fight Anti Infectives New Drugs, Medicines & Therapies ...
Oncology Conquering Cancer Inflammation & Immunology Innovation, Research & Development Vaccines Driven to Discover the Cure Rare Disease Our Approach to Gene Therapy and More Internal Medicine Advancing the Fight Anti Infectives New Drugs, Medicines & Therapies ...
By screening a single tumor tissue or blood sample for multiple biomarkers simultaneously, NGS can provide clinical teams with rapid and actionable genomic insights to help inform precision oncology treatment decisions for eligible patients.4 A retrospective observational real-world data study looke...
GrantsSupport for independent research Political PartnershipSupporting like-minded organizations Working with Healthcare ProfessionalsCollaboration to improve lives Prescription Value & PricingHow to lower patient costs Privacy PrinciplesCommitment to personal data privacy ...
20 minutes minimum delay|Feb 13, 2025 3:06 PM 02.29.2024 Pfizer Oncology Innovation Day PresentationInfographicTranscriptWebcast Events & Presentations 02.04.2025 Pfizer Quarterly Corporate Performance - Fourth Quarter 2024 Press Release(opens in new window) ...
Oncology is the only therapeutic area with an average regulatory review of less than 1 year; the 0.8-year duration is almost half as short as the cumulative total for all non-oncology indications (1.4 years). Urology drug candidates see the longest Phase 2 duration (5.0 years). Excluding ...